Laurence, Jeffrey C

Publications

Sort by

Co-Author Network

selected publications

MASP2 inhibition by narsoplimab suppresses endotheliopathies characteristic of transplant-associated thrombotic microangiopathy: in vitro and ex vivo evidence. Clinical and experimental immunology. 2023 Academic Article GET IT
Defibrotide mitigates endothelial cell injury induced by plasmas from patients with COVID-19 and related vasculopathies. Thrombosis research. 2023 Academic Article GET IT
Times cited: 1
Distinct inflammatory profiles linked to cardiovascular disease risk in HIV infection: implications for the design of preventive and therapeutic interventions. AIDS (London, England). 2023 Comment GET IT
The Recent Rise in Sexually Transmitted Infections in the United States Was a Harbinger of the New Monkeypox Pandemic. AIDS patient care and STDs. 2022 Academic Article GET IT
Times cited: 6
Long COVID endotheliopathy: hypothesized mechanisms and potential therapeutic approaches. The Journal of clinical investigation. 2022 Review GET IT
Times cited: 32
Atypical hemolytic uremic syndrome after myomectomy: A case report. 2022 GET IT
Times cited: 1
C5b-9 and MASP2 deposition in skin and bone marrow microvasculature characterize hematopoietic stem cell transplant-associated thrombotic microangiopathy. Bone marrow transplantation. 2022 Letter GET IT
Times cited: 3
Premortem Skin Biopsy Assessing Microthrombi, Interferon Type I Antiviral and Regulatory Proteins, and Complement Deposition Correlates with Coronavirus Disease 2019 Clinical Stage. The American journal of pathology. 2022 Academic Article GET IT
Times cited: 8
Intersecting Pandemics of Epidemiology, Inequality, Genetics, and Immunology: COVID-19 and AIDS. AIDS patient care and STDs. 2022 Academic Article GET IT
Times cited: 2
Angiopoietin 2 Is Associated with Vascular Necroptosis Induction in Coronavirus Disease 2019 Acute Respiratory Distress Syndrome. The American journal of pathology. 2022 Academic Article GET IT
Times cited: 11
Use of eculizumab in autologous hematopoietic stem cell transplantation-associated thrombotic microangiopathy in two adults. Leukemia & lymphoma. 2021 Letter GET IT
Times cited: 2
L-SIGN is a receptor on liver sinusoidal endothelial cells for SARS-CoV-2 virus. JCI insight. 2021 Academic Article GET IT
Times cited: 22
The skin as a critical window in unveiling the pathophysiologic principles of COVID-19. Clinics in dermatology. 2021 Review GET IT
Times cited: 20
Tissue factor upregulation is associated with SARS-CoV-2 in the lungs of COVID-19 patients. Journal of thrombosis and haemostasis : JTH. 2021 Academic Article GET IT
Times cited: 25
Severe COVID-19: A multifaceted viral vasculopathy syndrome. Annals of diagnostic pathology. 2020 Academic Article GET IT
Times cited: 57
Docked severe acute respiratory syndrome coronavirus 2 proteins within the cutaneous and subcutaneous microvasculature and their role in the pathogenesis of severe coronavirus disease 2019. Human pathology. 2020 Academic Article GET IT
Times cited: 23
The differing pathophysiologies that underlie COVID-19-associated perniosis and thrombotic retiform purpura: a case series. 2020 GET IT
Times cited: 75
Anti-complement C5 therapy with eculizumab in three cases of critical COVID-19. 2020 GET IT
Times cited: 85
MASP2 levels are elevated in thrombotic microangiopathies: association with microvascular endothelial cell injury and suppression by anti-MASP2 antibody narsoplimab. Clinical and experimental immunology. 2020 Academic Article GET IT
Times cited: 32
HIV protease inhibitor ritonavir induces renal fibrosis and dysfunction: role of platelet-derived TGF-β1 and intervention via antioxidant pathways. AIDS (London, England). 2020 Academic Article GET IT
Times cited: 4
Recurrent Complement-Mediated Thrombotic Microangiopathy in a Patient with Systemic Lupus Erythematosus: A Clinical Pathology Conference Held by the Division of Rheumatology at Hospital for Special Surgery. HSS journal : the musculoskeletal journal of Hospital for Special Surgery. 2020 Academic Article GET IT
Times cited: 579
Academia Europaea Position Paper on Translational Medicine: The Cycle Model for Translating Scientific Results into Community Benefits. Journal of clinical medicine. 2020 Academic Article GET IT
Times cited: 58
Why Aren't People Living with HIV at Higher Risk for Developing Severe Coronavirus Disease 2019 (COVID-19)?. AIDS patient care and STDs. 2020 Academic Article GET IT
Times cited: 45
Complement associated microvascular injury and thrombosis in the pathogenesis of severe COVID-19 infection: A report of five cases. Translational research : the journal of laboratory and clinical medicine. 2020 Academic Article GET IT
Times cited: 1507
Defining treatment duration in atypical hemolytic uremic syndrome in adults: a clinical and pathological approach. Clinical advances in hematology & oncology : H&O. 2020 Review GET IT
Times cited: 5
Economic Impact of Early-in-Hospital Diagnosis and Initiation of Eculizumab in Atypical Haemolytic Uraemic Syndrome. PharmacoEconomics. 2020 Academic Article GET IT
Times cited: 7
Pre-Exposure Prophylaxis (PrEP) for HIV: Opportunities, Challenges, and Future Directions. AIDS patient care and STDs. 2018 Academic Article GET IT
Times cited: 5
Death from Transfusion-Transmitted Anaplasmosis, New York, USA, 2017. 2018 GET IT
Times cited: 17
HIV-associated cardiovascular disease: importance of platelet activation and cardiac fibrosis in the setting of specific antiretroviral therapies. Open heart. 2018 Review GET IT
Times cited: 18
In Gratitude: Personal Memories of the Late Dr. Mathilde Krim (July 9, 1926-January 15, 2018). AIDS patient care and STDs. 2018 Academic Article GET IT
HIV protease inhibitor-induced cardiac dysfunction and fibrosis is mediated by platelet-derived TGF-β1 and can be suppressed by exogenous carbon monoxide. PloS one. 2017 Academic Article GET IT
Times cited: 20
Role of Platelet-Derived Transforming Growth Factor-β1 and Reactive Oxygen Species in Radiation-Induced Organ Fibrosis. Antioxidants & redox signaling. 2017 Review GET IT
Times cited: 48
A Cure for AIDS. AIDS patient care and STDs. 2016 Academic Article GET IT
Atypical hemolytic uremic syndrome (aHUS): essential aspects of an accurate diagnosis. Clinical advances in hematology & oncology : H&O. 2016 Review GET IT
Times cited: 69
Thrombotic Microangiopathy in the Setting of HIV Infection: A Case Report and Review of the Differential Diagnosis and Therapy. AIDS patient care and STDs. 2016 Review GET IT
Times cited: 18
Recognition and treatment of syndromes linked to dysregulation of the alternative complement pathway. Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis. 2016 Editorial Article GET IT
Times cited: 2
The role of complement activation in thrombosis and hemolytic anemias. Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis. 2016 Review GET IT
Times cited: 40
Brief Biography: Jeffrey Laurence, MD. Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis. 2016 Review GET IT
Transforming growth factor-β1-mediated cardiac fibrosis: potential role in HIV and HIV/antiretroviral therapy-linked cardiovascular disease. AIDS (London, England). 2016 Review GET IT
Times cited: 18
Role of the skin biopsy in the diagnosis of atypical hemolytic uremic syndrome. The American Journal of dermatopathology. 2015 Academic Article GET IT
Times cited: 29
Centennial celebration of translational research: the Journal of Laboratory and Clinical Medicine. Translational research : the journal of laboratory and clinical medicine. 2014 Editorial Article GET IT
Times cited: 2
Hematopoietic transplant-associated thrombotic microangiopathy: case report and review of diagnosis and treatments. Clinical advances in hematology & oncology : H&O. 2014 Review GET IT
Times cited: 37
The effects of Eculizumab on the pathology of malignant atrophic papulosis. 2013 GET IT
Times cited: 44
Support for translational research: exhausting all the possibilities. Translational research : the journal of laboratory and clinical medicine. 2013 Editorial Article GET IT
Use of eculizumab in the treatment of a case of refractory, ADAMTS13-deficient thrombotic thrombocytopenic purpura: additional data and clinical follow-up. British journal of haematology. 2013 Letter GET IT
Times cited: 38
Complement factor H mutations are present in ADAMTS13-deficient, ticlopidine-associated thrombotic microangiopathies. Blood. 2013 Letter GET IT
Times cited: 20
Atypical hemolytic uremic syndrome (aHUS): making the diagnosis. Clinical advances in hematology & oncology : H&O. 2012 Review GET IT
Times cited: 61
Diagnosis of atypical hemolytic uremic syndrome: a review of case studies. Clinical advances in hematology & oncology : H&O. 2012 Review GET IT
Times cited: 2
Combined factor V and factor VIII deficiency: a report of a case, genetic analysis, and response to desmopressin acetate. 2012 GET IT
Times cited: 6
Eculizumab in the treatment of refractory idiopathic thrombotic thrombocytopenic purpura. British journal of haematology. 2012 Letter GET IT
Times cited: 79
Disturbing the "Thunderous Silence" on AIDS: a tribute to Dame Elizabeth Taylor. AIDS patient care and STDs. 2011 Academic Article GET IT
Noncanonical Wnt signaling promotes osteoclast differentiation and is facilitated by the human immunodeficiency virus protease inhibitor ritonavir. Biochemical and biophysical research communications. 2011 Academic Article GET IT
Times cited: 42
Translating ideas into action: two new features initiated by Translational Research, as genomics enters the clinics. Translational research : the journal of laboratory and clinical medicine. 2011 Editorial Article GET IT
Times cited: 2
Stem cell ping-pong: the politics of science. Translational research : the journal of laboratory and clinical medicine. 2010 Editorial Article GET IT
Times cited: 1
Effects of HIV infection and antiretroviral therapy with ritonavir on induction of osteoclast-like cells in postmenopausal women. Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA. 2010 Academic Article GET IT
Times cited: 24
Low bone mass and high bone turnover in postmenopausal human immunodeficiency virus-infected women. The Journal of clinical endocrinology and metabolism. 2009 Academic Article GET IT
Times cited: 76
Getting personal: the promises and pitfalls of personalized medicine. Translational research : the journal of laboratory and clinical medicine. 2009 Academic Article GET IT
Times cited: 9
Sustained release of microbicides by newly engineered vaginal rings. AIDS (London, England). 2009 Academic Article GET IT
Times cited: 45
Start anti-HIV treatment early, in adults and infants. The AIDS reader. 2009 Editorial Article GET IT
WNT/beta-catenin signaling is involved in regulation of osteoclast differentiation by human immunodeficiency virus protease inhibitor ritonavir: relationship to human immunodeficiency virus-linked bone mineral loss. The American journal of pathology. 2008 Academic Article GET IT
Times cited: 44
No more boring science, no more waste in clinical trials. Translational research : the journal of laboratory and clinical medicine. 2008 Editorial Article GET IT
Times cited: 3
Preventing sexually transmitted infections, 2008. The AIDS reader. 2008 Editorial Article GET IT
Choosing optimal antiretroviral therapies in 2008. The AIDS reader. 2008 Editorial Article GET IT
Mexico City: a call for "universal action now". The AIDS reader. 2008 Editorial Article GET IT
Compartmentalizing AIDS. The AIDS reader. 2008 Editorial Article GET IT
Keratinization: a biologic alternative to male circumcision in the prevention of HIV infection?. The AIDS reader. 2008 Editorial Article GET IT
Times cited: 1
HPV-linked oral cancer: another argument for universal HPV vaccination of boys and girls. The AIDS reader. 2008 Editorial Article GET IT
Times cited: 6
Learn a new trade: repairing broken pipelines. Translational research : the journal of laboratory and clinical medicine. 2008 Editorial Article GET IT
Times cited: 1
Treating HIV: when to start, who should treat, and still missing many. The AIDS reader. 2008 Editorial Article GET IT
Times cited: 1
Seeking a cure for AIDS. The AIDS reader. 2008 Editorial Article GET IT
Times cited: 2
Biomedical methods for HIV prevention: new setbacks. The AIDS reader. 2008 Editorial Article GET IT
Synergistic interactions between interferon-gamma and TRAIL modulate c-FLIP in endothelial cells, mediating their lineage-specific sensitivity to thrombotic thrombocytopenic purpura plasma-associated apoptosis. Blood. 2008 Academic Article GET IT
Times cited: 20
Durability of clinical responses to anti-HIV therapies. The AIDS reader. 2008 Editorial Article GET IT
Times cited: 1
Recent highlights in clinical AIDS research. The AIDS reader. 2008 Editorial Article GET IT
Two months of AIDS reports: critical lessons for HIV biology and medicine. The AIDS reader. 2008 Editorial Article GET IT
Women and HIV. The AIDS reader. 2007 Editorial Article GET IT
Times cited: 1
Making HIV testing routine. The AIDS reader. 2007 Editorial Article GET IT
Times cited: 1
Modeling metabolic effects of the HIV protease inhibitor ritonavir in vitro. The American journal of pathology. 2007 Letter GET IT
Times cited: 2
Non-AIDS-defining malignancies and HAART. The AIDS reader. 2007 Editorial Article GET IT
Times cited: 2
Men who have sex with men: a new focus internationally. The AIDS reader. 2007 Editorial Article GET IT
Times cited: 7
A cure for AIDS?. The AIDS reader. 2007 Editorial Article GET IT
Times cited: 1
HIV variants of low frequency may have a big impact. The AIDS reader. 2007 Editorial Article GET IT
Curb your enthusiasm. Translational research : the journal of laboratory and clinical medicine. 2007 Editorial Article GET IT
Times cited: 1
Pivotal moments in HIV treatment: the 14th CROI. The AIDS reader. 2007 Editorial Article GET IT
The "missing face" of AIDS. The AIDS reader. 2007 Editorial Article GET IT
Highlights of a year in AIDS. The AIDS reader. 2007 Editorial Article GET IT
Times cited: 3
Know your epidemic. The AIDS reader. 2007 Editorial Article GET IT
Antiretroviral suppression of HIV in the context of persistently low CD4 counts: new insights. The AIDS reader. 2007 Editorial Article GET IT
Two areas in urgent need of HIV-related prevention: injection drug use and extensively drug-resistant TB. The AIDS reader. 2006 Editorial Article GET IT
Recent studies of sexual transmission of HIV. The AIDS reader. 2006 Editorial Article GET IT
Bridging the gap between "ABC" and an AIDS vaccine. The AIDS reader. 2006 Editorial Article GET IT
Once-daily dosing and the treatment of HIV disease. The AIDS reader. 2006 Editorial Article GET IT
Times cited: 3
Treating HIV infection with one pill per day. AIDS patient care and STDs. 2006 Editorial Article GET IT
Times cited: 3
Surviving AIDS, and AIDS dementia. The AIDS reader. 2006 Editorial Article GET IT
Times cited: 1
AIDS fighter: Dr. Mathilde Krim. AIDS patient care and STDs. 2006 Academic Article GET IT
Translating translational research. Translational research : the journal of laboratory and clinical medicine. 2006 Editorial Article GET IT
Times cited: 8
Update: a 25th anniversary and a UN global AIDS summit. The AIDS reader. 2006 Editorial Article GET IT
Times cited: 3
Debating global HIV incidence. The AIDS reader. 2006 Editorial Article GET IT
Times cited: 5
Suppressing HIV transmission--through behavior and biology. The AIDS reader. 2006 Editorial Article GET IT
Times cited: 1
HIV therapy, guided by CD4 counts. The AIDS reader. 2006 Editorial Article GET IT
HCV infection in the setting of HIV: prevalence, disease, treatment. The AIDS reader. 2006 Editorial Article GET IT
Times cited: 3
Yet another World AIDS Day. The AIDS reader. 2006 Editorial Article GET IT
Times cited: 2
Hepatitis A and B virus immunization in HIV-infected persons. The AIDS reader. 2006 Editorial Article GET IT
Times cited: 2
The medical miracle: more questions. The AIDS reader. 2005 Editorial Article GET IT
Times cited: 2
Antiretrovirals in the pipeline: anticipated updates. The AIDS reader. 2005 Editorial Article GET IT
Times cited: 1
A medical miracle, but for how long?. The AIDS reader. 2005 Editorial Article GET IT
Times cited: 6
Hepatitis A and B immunizations of individuals infected with human immunodeficiency virus. The American journal of medicine. 2005 Review GET IT
Times cited: 106
Leads from the Third International AIDS Society conference. The AIDS reader. 2005 Editorial Article GET IT
Report from the National HIV Prevention Conference. The AIDS reader. 2005 Editorial Article GET IT
Times cited: 2
HIV and the lung in the HAART era. The AIDS reader. 2005 Editorial Article GET IT
Times cited: 1
Multidrug-resistant HIV. The AIDS reader. 2005 Editorial Article GET IT
Times cited: 3
HIV immune pathogenesis: an update from CROI. The AIDS reader. 2005 Editorial Article GET IT
Times cited: 1
Possible HIV "super-strain" in New York City; new human T-lymphotropic viruses identified in Africa. The AIDS reader. 2005 Editorial Article GET IT
Times cited: 1
Use of bone marrow examination in HIV/AIDS. The AIDS reader. 2005 Editorial Article GET IT
The role of prisons in dissemination of HIV and hepatitis. The AIDS reader. 2005 Editorial Article GET IT
Times cited: 1
Accessibility and longevity of Internet citations in a clinical AIDS journal. AIDS patient care and STDs. 2005 Review GET IT
Times cited: 13
HPV-linked malignancy and the potential of vaccine-based prevention. The AIDS reader. 2005 Editorial Article GET IT
Times cited: 6
Treating HIV infection without antiretrovirals; preventing HIV infection with them. The AIDS reader. 2004 Editorial Article GET IT
Mortality among patients with HIV infection in the HAART era. The AIDS reader. 2004 Editorial Article GET IT
Stroke and anemia in HIV/AIDS. The AIDS reader. 2004 Editorial Article GET IT
Times cited: 2
HIV-1 Vpr enhances production of receptor of activated NF-kappaB ligand (RANKL) via potentiation of glucocorticoid receptor activity. Archives of virology. 2004 Academic Article GET IT
Times cited: 85
Interactions among human immunodeficiency virus (HIV)-1, interferon-gamma and receptor of activated NF-kappa B ligand (RANKL): implications for HIV pathogenesis. Clinical and experimental immunology. 2004 Academic Article GET IT
Times cited: 35
XV International AIDS Conference: science versus political science. The AIDS reader. 2004 Editorial Article GET IT
New information for some old editorials. The AIDS reader. 2004 Editorial Article GET IT
Fighting a flexible virus with flexible drugs. The AIDS reader. 2004 Editorial Article GET IT
Times cited: 1
Treating primary HIV infection: HIV and the US sex-film industry. The AIDS reader. 2004 Editorial Article GET IT
Endothelial cell activation and apoptosis in the thrombotic microangiopathies. British journal of haematology. 2004 Letter GET IT
Times cited: 1
HAART, side effects, and viral transmission. The AIDS reader. 2004 Academic Article GET IT
Times cited: 3
Lessons from the 11th conference on retroviruses and opportunistic infections. The AIDS reader. 2004 Editorial Article GET IT
Newly identified human retrovirus receptor; new ways to prevent viral infections. The AIDS reader. 2004 Editorial Article GET IT
Pulse therapy. The AIDS reader. 2004 Editorial Article GET IT
Times cited: 1
HIV therapeutics in children and adults and their side effects. The AIDS reader. 2004 Editorial Article GET IT
Times cited: 2
Thienopyridine-linked thrombotic microangiopathy: association with endothelial cell apoptosis and activation of MAP kinase signalling cascades. British journal of haematology. 2004 Academic Article GET IT
Times cited: 35
New trends in HIV disease worldwide. The AIDS reader. 2003 Editorial Article GET IT
Times cited: 2
HAART, hepatitis C, activated T cells, and mortality. The AIDS reader. 2003 Editorial Article GET IT
Times cited: 1
Medication adherence rates and drug-resistant HIV: new data. The AIDS reader. 2003 Editorial Article GET IT
HIV envelope gp120-mediated regulation of osteoclastogenesis via receptor activator of nuclear factor kappa B ligand (RANKL) secretion and its modulation by certain HIV protease inhibitors through interferon-gamma/RANKL cross-talk. The Journal of biological chemistry. 2003 Academic Article GET IT
Times cited: 146
HIV epidemics, HIV therapeutics: recent trends. The AIDS reader. 2003 Editorial Article GET IT
HIV therapeutics, continued: another HIV protease inhibitor approved. The AIDS reader. 2003 Editorial Article GET IT
Times cited: 1
HIV therapeutics: points from the recent literature. The AIDS reader. 2003 Editorial Article GET IT
Times cited: 2
Repetitive mucosal exposure to human herpesvirus-8 and protection against its penile-vaginal transmission. The Journal of infectious diseases. 2003 Letter GET IT
Therapeutic vaccination for HIV disease. The AIDS reader. 2003 Editorial Article GET IT
Times cited: 3
Impact of HAART on HIV-linked malignancies. The AIDS reader. 2003 Editorial Article GET IT
Times cited: 13
Results of the first phase 3 trial of an AIDS vaccine. The AIDS reader. 2003 Editorial Article GET IT
Drug resistance among HIV and its "friends". The AIDS reader. 2003 Editorial Article GET IT
Times cited: 2
RNA silencing: a new therapeutic strategy against HIV. The AIDS reader. 2003 Editorial Article GET IT
Times cited: 1
Repetitive and consistent cervicovaginal exposure to certain viral pathogens appears to protect against their sexual acquisition in some women: potential mechanisms. Journal of reproductive immunology. 2003 Academic Article GET IT
Times cited: 11
On being a Kunkel acolyte. Lupus. 2003 Academic Article GET IT
Simplifying HIV therapeutics, and the global treatment of AIDS. The AIDS reader. 2003 Editorial Article GET IT
Times cited: 2
Identifying and modifying barriers to HIV testing and prevention. The AIDS reader. 2002 Editorial Article GET IT
T-20: a model for novel anti-HIV drugs in development. The AIDS reader. 2002 Editorial Article GET IT
Times cited: 2
Immune restoration and HAART: new clinical and in vitro data. The AIDS reader. 2002 Editorial Article GET IT
Times cited: 4
AIDS vaccines, immunology, and what we have learned. The AIDS reader. 2002 Editorial Article GET IT
Prevention vs. treatment and the future of HIV medical care. AIDS patient care and STDs. 2002 Editorial Article GET IT
Times cited: 1
Changes in HIV-related diseases and the future of HIV medical care. The AIDS reader. 2002 Editorial Article GET IT
CD4 cell depletion in AIDS: models for novel therapies. The AIDS reader. 2002 Editorial Article GET IT
Times cited: 1
Potential roles for chemokine receptor CCR5 in the pathobiology of hepatitis C infection. Gastroenterology. 2002 Editorial Article GET IT
Times cited: 8
9th National Retrovirus Conference: new treatments, new choices. AIDS patient care and STDs. 2002 Editorial Article GET IT
Update from Seattle: the 9th Annual Retrovirus Conference. The AIDS reader. 2002 Editorial Article GET IT
"Scientific gambles": AIDS microbicides and vaccines. The AIDS reader. 2002 Editorial Article GET IT
More hot topics in HIV/AIDS. The AIDS reader. 2002 Editorial Article GET IT
Bullet points: new topics in HIV/AIDS. AIDS patient care and STDs. 2002 Editorial Article GET IT
Hot topics in AIDS therapeutics. The AIDS reader. 2002 Editorial Article GET IT
Times cited: 1
Coinfection with hepatitis viruses and HIV: good and bad news. AIDS patient care and STDs. 2001 Review GET IT
Times cited: 2
Immune reconstitution and HAART: an update. The AIDS reader. 2001 Editorial Article GET IT
Times cited: 1
Fighting virus with virus? GB virus C and HIV coinfections. The AIDS reader. 2001 Editorial Article GET IT
Times cited: 3
Clinical AIDS updates: disease trends, new drug-resistance concerns. AIDS patient care and STDs. 2001 Editorial Article GET IT
Drug-resistant HIV: predicting the future. The AIDS reader. 2001 Editorial Article GET IT
Designing an AIDS vaccine. AIDS patient care and STDs. 2001 Editorial Article GET IT
Endothelial cell apoptotic genes associated with the pathogenesis of thrombotic microangiopathies: an application of oligonucleotide genechip technology. Microvascular research. 2001 Academic Article GET IT
Times cited: 13
Further thoughts on drug resistance in HIV infection. The AIDS reader. 2001 Editorial Article GET IT
Times cited: 1
'Reverse gear' cellular movement mediated by chemokines. Immunology and cell biology. 2001 Academic Article GET IT
Times cited: 21
Drug-resistant HIV. The AIDS reader. 2001 Editorial Article GET IT
The cost effectiveness of antiretroviral therapy for HIV disease. The New England journal of medicine. 2001 Letter GET IT
Times cited: 7
June 5, 2001: marking 20 years since the recognition of AIDS. AIDS patient care and STDs. 2001 Editorial Article GET IT
AIDS: 20th Anniversary, June 2001. The AIDS reader. 2001 Editorial Article GET IT
Times cited: 2
Facial wasting. The AIDS reader. 2001 Academic Article GET IT
Cost-effectiveness of HIV therapies in different economic worlds. The AIDS reader. 2001 Editorial Article GET IT
Times cited: 2
Peptides derived from salivary thrombospondin-1 replicate its anti-HIV effect: potential role in microbicide development. Journal of acquired immune deficiency syndromes (1999). 2001 Letter GET IT
Times cited: 10
Compliance with antiretroviral regimens. The AIDS reader. 2001 Editorial Article GET IT
Times cited: 1
Adhering to antiretroviral therapies. AIDS patient care and STDs. 2001 Editorial Article GET IT
Times cited: 7
Emerging manifestations of HIV/AIDS: is it the virus or the antiviral therapy?. The AIDS reader. 2001 Editorial Article GET IT
Role of transforming growth factor beta1 in microvascular endothelial cell apoptosis associated with thrombotic thrombocytopenic purpura and hemolytic-uremic syndrome. American journal of hematology. 2001 Academic Article GET IT
Times cited: 19
The initial patient visit: choosing an optimal antiretroviral strategy. The AIDS reader. 2000 Editorial Article GET IT
Times cited: 1
HIV/AIDS in South Africa: the epidemic in numbers. The AIDS reader. 2000 Editorial Article GET IT
Times cited: 2
Tracking T cell loss in simian-human immunodeficiency virus infection. AIDS patient care and STDs. 2000 Editorial Article GET IT
Viral resistance testing: new data from the XIII International AIDS Conference. The AIDS reader. 2000 Editorial Article GET IT
XIIIth International AIDS Conference: a continuing update. AIDS patient care and STDs. 2000 Editorial Article GET IT
XIII International AIDS Conference highlights. The AIDS reader. 2000 Academic Article GET IT
XIIIth International AIDS Conference: new thoughts on old drugs. AIDS patient care and STDs. 2000 Editorial Article GET IT
HIV prevention and treatment in Africa. AIDS patient care and STDs. 2000 Editorial Article GET IT
Times cited: 2
XIII international AIDS Conference: new thoughts on treatment in all worlds. The AIDS reader. 2000 Editorial Article GET IT
Times cited: 1
Update: AIDS malignancies, AIDS prevention. The AIDS reader. 2000 Editorial Article GET IT
Times cited: 1
AIDS lessons from South Africa. AIDS patient care and STDs. 2000 Editorial Article GET IT
Times cited: 1
South Africa on the eve of the XIIIth International AIDS Conference. The AIDS reader. 2000 Editorial Article GET IT
Times cited: 1
Accelerated bone mineral loss in HIV-positive patients. The AIDS reader. 2000 Editorial Article GET IT
Times cited: 5
Reconsidering antiretroviral therapy in HIV: lessons from San Francisco. AIDS patient care and STDs. 2000 Editorial Article GET IT
Times cited: 2
Antiretroviral therapy in HIV/AIDS: update from San Francisco. The AIDS reader. 2000 Editorial Article GET IT
Times cited: 5
HIV in prison; HIV and killer T cells. AIDS patient care and STDs. 2000 Editorial Article GET IT
Times cited: 1
Pathological and therapeutic distinctions in HUS/TTP. Lancet (London, England). 2000 Letter GET IT
Times cited: 10
AIDS and the new millennium. AIDS patient care and STDs. 2000 Editorial Article GET IT
Times cited: 2
"Amplified perversity": trends in heterosexual HIV. AIDS patient care and STDs. 1999 Editorial Article GET IT
Times cited: 1
Stopping heterosexual HIV. The AIDS reader. 1999 Editorial Article GET IT
Stopping vertical transmission of HIV: global strategies. AIDS patient care and STDs. 1999 Editorial Article GET IT
Preventing mother-to-infant transmission of HIV in the developing world. The AIDS reader. 1999 Editorial Article GET IT
Times cited: 1
Salvage II. The AIDS reader. 1999 Editorial Article GET IT
Transfusing blood: supply and demand. AIDS patient care and STDs. 1999 Editorial Article GET IT
Therapeutic implications of recent data on immune pathogenesis of HIV disease. AIDS patient care and STDs. 1999 Editorial Article GET IT
Times cited: 1
AIDS and lipodystrophy: complications of HIV and HIV treatments. AIDS patient care and STDs. 1999 Editorial Article GET IT
Salvaging HAART. The AIDS reader. 1999 Editorial Article GET IT
Treatment news: 6th Conference on Retroviruses and Opportunistic Infections. AIDS patient care and STDs. 1999 Editorial Article GET IT
Post-exposure prophylaxis: a new form of prevention?. AIDS patient care and STDs. 1999 Editorial Article GET IT
Global challenges of the AIDS epidemic: perspectives. Introductory remarks. AIDS patient care and STDs. 1999 Academic Article GET IT
HIV laws: a new shift in focus. AIDS patient care and STDs. 1999 Editorial Article GET IT
Enhanced endothelial cell apoptosis in splenic tissues of patients with thrombotic thrombocytopenic purpura. Blood. 1999 Academic Article GET IT
Times cited: 66
Women and AIDS. AIDS patient care and STDs. 1999 Editorial Article GET IT
AIDS and emerging infectious diseases. The AIDS reader. 1999 Editorial Article GET IT
Highlights of the 6th Conference on Retroviruses and Opportunistic Infections. The AIDS reader. 1999 Editorial Article GET IT
The answers continue. The AIDS reader. 1999 Editorial Article GET IT
The usual state of emergency. AIDS patient care and STDs. 1999 Editorial Article GET IT
AIDS research and its cultural implications. AIDS patient care and STDs. 1998 Academic Article GET IT
Pathologic distinctions among the thrombotic microangiopathies. Clinical nephrology. 1998 Letter GET IT
Times cited: 1
Role of caspases 1 and 3 and Bcl-2-related molecules in endothelial cell apoptosis associated with thrombotic microangiopathies. American journal of hematology. 1998 Academic Article GET IT
Times cited: 37
Talking about anti-viral drug regimens: 38th annual ICAAC Interscience Conference on Antimicrobial Agents and Chemotherapy. AIDS patient care and STDs. 1998 Editorial Article GET IT
Viral resistance: new calls for prevention. AIDS patient care and STDs. 1998 Editorial Article GET IT
12th World AIDS Conference: pointing out the gaps. AIDS patient care and STDs. 1998 Editorial Article GET IT
Hepatitis C in the setting of HIV. AIDS patient care and STDs. 1998 Editorial Article GET IT
Vascular complications associated with use of HIV protease inhibitors. Lancet (London, England). 1998 Letter GET IT
Times cited: 40
Sexual behaviors and health belief models. AIDS patient care and STDs. 1998 Editorial Article GET IT
Saying "no" to HIV prevention. AIDS patient care and STDs. 1998 Editorial Article GET IT
Micronutrients and HIV infection. AIDS patient care and STDs. 1998 Editorial Article GET IT
HIV prevention strategies: quo vadis?. AIDS patient care and STDs. 1998 Editorial Article GET IT
Another medicine? Another ethics?. AIDS patient care and STDs. 1998 Editorial Article GET IT
Times cited: 1
Identification of a CD36-related thrombospondin 1-binding domain in HIV-1 envelope glycoprotein gp120: relationship to HIV-1-specific inhibitory factors in human saliva. The Journal of experimental medicine. 1998 Academic Article GET IT
Times cited: 78
HAART therapy: dividing the epidemic?. AIDS patient care and STDs. 1997 Editorial Article GET IT
AIDS and endocrinology. AIDS patient care and STDs. 1997 Editorial Article GET IT
Interaction of pregnancy steroid hormones and zidovudine in inhibition of HIV type 1 replication in monocytoid and placental Hofbauer cells: implications for the prevention of maternal-fetal transmission of HIV. AIDS research and human retroviruses. 1997 Academic Article GET IT
Times cited: 22
Preventing AIDS by targeting other STDs. AIDS patient care and STDs. 1997 Editorial Article GET IT
Times cited: 3
"When do I start?"; "what do I start with?"; and "when should I switch?". AIDS patient care and STDs. 1997 Editorial Article GET IT
Stable human immunodeficiency virus type 1 (HIV-1) resistance in transformed CD4+ monocytic cells treated with multitargeting HIV-1 antisense sequences incorporated into U1 snRNA. Journal of virology. 1997 Academic Article GET IT
Times cited: 32
Apoptosis of microvascular endothelial cells in the pathophysiology of thrombotic thrombocytopenic purpura/sporadic hemolytic uremic syndrome. Seminars in hematology. 1997 Review GET IT
Times cited: 34
Important new findings concerning the pathophysiology and treatment of HIV/AIDS were presented at the 4th Conference on Retroviruses and Opportunistic Infections, held in Washington, DC, January 22-26, 1997. AIDS patient care and STDs. 1997 Editorial Article GET IT
Quantitative RT-PCR for human Fas (CD95) expression. BioTechniques. 1997 Academic Article GET IT
Times cited: 3
Soluble factor of transformed B lymphocytes in patients with HIV infection stimulates monocytes to produce PGE2. Clinical immunology and immunopathology. 1997 Academic Article GET IT
Times cited: 8
Thrombotic thrombocytopenic purpura and sporadic hemolytic-uremic syndrome plasmas induce apoptosis in restricted lineages of human microvascular endothelial cells. Blood. 1997 Academic Article GET IT
Times cited: 172
Recent successes in the antiretroviral therapy of HIV infections. AIDS patient care and STDs. 1996 Editorial Article GET IT
We're closing in on HIV. AIDS patient care and STDs. 1996 Editorial Article GET IT
Times cited: 1
Preclinical data on the antiretroviral activity of AZT. AIDS patient care and STDs. 1996 Editorial Article GET IT
Times cited: 1
Concerns, from public policy to public health and experimental therapeutics. AIDS patient care and STDs. 1996 Editorial Article GET IT
Times cited: 1
Plasma from patients with idiopathic and human immunodeficiency virus-associated thrombotic thrombocytopenic purpura induces apoptosis in microvascular endothelial cells. Blood. 1996 Academic Article GET IT
Times cited: 116
A critical report from the Office of AIDS Research Advisory Council. AIDS patient care and STDs. 1996 Editorial Article GET IT
HIV-1 upregulates Fas ligand expression in CD4+ T cells in vitro and in vivo: association with Fas-mediated apoptosis and modulation by aurintricarboxylic acid. Immunology. 1996 Academic Article GET IT
Times cited: 101
Apoptotic depletion of CD4+ T cells in idiopathic CD4+ T lymphocytopenia. The Journal of clinical investigation. 1996 Academic Article GET IT
Times cited: 90
The HIV/AIDS pandemic and the evolving role of primary care. AIDS patient care and STDs. 1996 Editorial Article GET IT
Role of glucocorticoid receptor binding sites in the human immunodeficiency virus type 1 long terminal repeat in steroid-mediated suppression of HIV gene expression. Virology. 1995 Academic Article GET IT
Times cited: 38
Growth hormone in HIV/AIDS: current uses and future prospects. Pediatric AIDS and HIV infection. 1995 Review GET IT
Times cited: 10
Immunodominant epitope regions of HIV-1 reverse transcriptase: correlations with HIV-1+ serum IgG inhibitory to polymerase activity and with disease progression. Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association. 1995 Academic Article GET IT
Times cited: 8
Neutrophils from human immunodeficiency virus (HIV)-seronegative donors induce HIV replication from HIV-infected patients' mononuclear cells and cell lines: an in vitro model of HIV transmission facilitated by Chlamydia trachomatis. The Journal of experimental medicine. 1995 Academic Article GET IT
Times cited: 64
CD4+ and CD8+ T lymphocyte activation in HIV infection. Implications for immune pathogenesis and therapy. Advances in experimental medicine and biology. 1995 Review GET IT
Times cited: 6
AIDS research: the second decade. AIDS research and human retroviruses. 1994 Review GET IT
Times cited: 4
Withdrawal of conclusion: false positive tests for HIV in a woman with lupus. The New England journal of medicine. 1994 Letter GET IT
Times cited: 8
HIV-induced T-lymphocyte depletion. Clinics in laboratory medicine. 1994 Review GET IT
Times cited: 12
CD4+ lymphocytopenia in systemic lupus erythematosus. Annals of internal medicine. 1994 Letter GET IT
Times cited: 16
Identification of a novel cell-type and context specific enhancer within the negative regulatory element of the human immunodeficiency virus type 1 long terminal repeat. Archives of virology. 1994 Academic Article GET IT
Times cited: 7
Inhibition of tat-activated, HIV-1 long terminal repeat-mediated gene expression by glucocorticoids. AIDS research and human retroviruses. 1993 Letter GET IT
Times cited: 8
Reservoirs of HIV infection or carriage: monocytic, dendritic, follicular dendritic, and B cells. Annals of the New York Academy of Sciences. 1993 Review GET IT
Times cited: 11
A model system for regulation of chronic HIV-1 infection in peripheral B lymphocytes. Virology. 1993 Academic Article GET IT
Times cited: 6
T-cell subsets in health, infectious disease, and idiopathic CD4+ T lymphocytopenia. Annals of internal medicine. 1993 Review GET IT
Times cited: 151
CD4+ T-lymphocytopenia without HIV infection. The New England journal of medicine. 1993 Letter GET IT
Times cited: 12
CD4+ T-lymphocytopenia without HIV infection. The New England journal of medicine. 1993 Letter GET IT
Superantigens in infectious diseases, including AIDS. Annals of the New York Academy of Sciences. 1993 Review GET IT
Times cited: 7
Acquired immunodeficiency without evidence of infection with human immunodeficiency virus types 1 and 2. 1992 GET IT
Times cited: 66
Superantigen implicated in dependence of HIV-1 replication in T cells on TCR V beta expression. Nature. 1992 Academic Article GET IT
Times cited: 143
Human immunodeficiency virus activates c-myc and Epstein-Barr virus in human B lymphocytes. Annals of the New York Academy of Sciences. 1992 Academic Article GET IT
Times cited: 17
Effect of recombinant human growth hormone on acute and chronic human immunodeficiency virus infection in vitro. Blood. 1992 Academic Article GET IT
Times cited: 36
Does HIV infection of B lymphocytes initiate AIDS lymphoma? Detection by PCR of viral sequences in lymphoma tissue. Current topics in microbiology and immunology. 1992 Academic Article GET IT
Times cited: 11
Human immunodeficiency virus induction of malignant transformation in human B lymphocytes. Proceedings of the National Academy of Sciences of the United States of America. 1991 Academic Article GET IT
Times cited: 95
A cluster of Pneumocystis carinii pneumonia in adults without predisposing illnesses. 1991 GET IT
Times cited: 136
AIDS risk knowledge, attitudes, and behavioral intentions among multi-ethnic adolescents. AIDS education and prevention : official publication of the International Society for AIDS Education. 1991 Academic Article GET IT
Times cited: 18
Induction of chronic human immunodeficiency virus infection is blocked in vitro by a methylphosphonate oligodeoxynucleoside targeted to a U3 enhancer element. Journal of virology. 1991 Academic Article GET IT
Times cited: 27
Immunology of HIV infection, I: Biology of the interferons. AIDS research and human retroviruses. 1990 Review GET IT
Times cited: 20
Molecular interactions among herpesviruses and human immunodeficiency viruses. The Journal of infectious diseases. 1990 Review GET IT
Times cited: 69
A soluble inhibitor of T lymphocyte function induced by HIV-1 infection of CD4+ T cells: characterization of a cellular protein and its relationship to p15E. Cellular immunology. 1990 Academic Article GET IT
Times cited: 11
Human immunodeficiency virus infection of monocytes: relationship to Fc-gamma receptors and antibody-dependent viral enhancement. Immunology. 1990 Academic Article GET IT
Times cited: 24
Effect of tamoxifen on regulation of viral replication and human immunodeficiency virus (HIV) long terminal repeat-directed transcription in cells chronically infected with HIV-1. Blood. 1990 Academic Article GET IT
Times cited: 48
Novel vaccination and antireceptor strategies against HIV. AIDS research and human retroviruses. 1990 Review GET IT
Times cited: 2
Phorbol ester-mediated induction of HIV-1 from a chronically infected promonocyte clone: blockade by protein kinase inhibitors and relationship to tat-directed trans-activation. Biochemical and biophysical research communications. 1990 Academic Article GET IT
Times cited: 29
A multicenter clinical trial of oral ribavirin in HIV-infected people with lymphadenopathy: virologic observations. Ribavirin-LAS Collaborative Group. AIDS (London, England). 1990 Academic Article GET IT
Times cited: 18
Effect of glucocorticoids on chronic human immunodeficiency virus (HIV) infection and HIV promoter-mediated transcription. Blood. 1989 Academic Article GET IT
Times cited: 38
Human immunodeficiency virus infection of helper T cell clones. Early proliferative defects despite intact antigen-specific recognition and interleukin 4 secretion. The Journal of clinical investigation. 1989 Academic Article GET IT
Times cited: 27
AIDS 1989. Vaccines and immunology: overview. AIDS (London, England). 1989 Review GET IT
Times cited: 1
AIDS. Current medical and scientific aspects. The Journal of legal medicine. 1988 Review GET IT
Update: HIV-1 gene nomenclature. AIDS research and human retroviruses. 1988 Editorial Article GET IT
Times cited: 2
Macrophage biology, latency, and HIV infection. AIDS research and human retroviruses. 1988 Editorial Article GET IT
Times cited: 1
Vaccines and immunology. Overview. AIDS (London, England). 1988 Review GET IT
PolyI.polyC12U-mediated inhibition of loss of alloantigen responsiveness viral replication in human CD4+ T cell clones exposed to human immunodeficiency virus in vitro. The Journal of clinical investigation. 1987 Academic Article GET IT
Times cited: 10
Ribavirin pharmacodynamics in high-risk patients for acquired immunodeficiency syndrome. Clinical pharmacology and therapeutics. 1987 Academic Article GET IT
Times cited: 36
Characterization and clinical association of antibody inhibitory to HIV reverse transcriptase activity. Science (New York, N.Y.). 1987 Academic Article GET IT
Times cited: 57
The immune system in AIDS. Scientific American. 1985 Academic Article GET IT
Times cited: 19
Naturally occurring antibodies reactive with sperm proteins: apparent deficiency in AIDS sera. Science (New York, N.Y.). 1985 Academic Article GET IT
Times cited: 25
Lymphadenopathy-associated viral antibody in AIDS. Immune correlations and definition of a carrier state. The New England journal of medicine. 1984 Academic Article GET IT
Times cited: 89
Immunoregulatory lymphokines of T hybridomas from AIDS patients: constitutive and inducible suppressor factors. Science (New York, N.Y.). 1984 Academic Article GET IT
Times cited: 37
Lymphocyte markers in health and disease. Disease-a-month : DM. 1984 Review GET IT
Times cited: 2
Soluble factors inhibitory for T-cell-dependent immune responses in patients with the acquired immune deficiency syndrome and its prodromes. Annals of the New York Academy of Sciences. 1984 Academic Article GET IT
Times cited: 1
Soluble suppressor factors in patients with acquired immune deficiency syndrome and its prodrome. Elaboration in vitro by T lymphocyte-adherent cell interactions. The Journal of clinical investigation. 1983 Academic Article GET IT
Times cited: 79
Combination chemotherapy of advanced diffuse histiocytic lymphoma with the six-drug COP-BLAM regimen. Annals of internal medicine. 1982 Academic Article GET IT
Times cited: 144
Cryoglobulinemia. Disease-a-month : DM. 1981 Academic Article GET IT
Times cited: 11
Proliferative response of T lymphocytes to allogeneic tumor without generation of killer T lymphocytes in the presence of Ehrlich ascites tumor fluid. Gan. 1976 Academic Article GET IT

more ...

less ...

Background

education and training

M.D., University of Chicago Pritzker School of Medicine 1976
B.A., Columbia University 1972

Contact

full name

Jeffrey C Laurence

primary email

jlaurenc@med.cornell.edu

webpage

Clinical Profile

VIVO Weill Cornell Medical College

Jeffrey C Laurence Professor of Medicine

Publications

selected publications

Background

education and training

Contact

full name

primary email

webpage

Phone

Publications

selected publications

Background

education and training

Contact

full name

primary email

webpage